Ikena Oncology Inc Financial Flexibility Index
Ikena Oncology Inc financial flexibility index. Ikena Oncology Inc (IKNA) has a Financial Flexibility Index of -0.33x as of June 2025. Free cash flow of $-3.42 Million (operating CF $-3.42 Million minus capex $0.00) represents 0% of total liabilities ($10.26 Million). See Ikena Oncology Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ikena Oncology Inc (2018–2024)
Financial flexibility index of Ikena Oncology Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Ikena Oncology Inc across 7 annual periods. Check IKNA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Ikena Oncology Inc Financial Flexibility Index by Year (2018–2024)
Ikena Oncology Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Ikena Oncology Inc. For the full cash flow conversion analysis, see IKNA cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.95x | $-46.00 Million | $-46.00 Million | $15.58 Million | ▲ +16.8% |
| 2023 | -3.55x | $-79.33 Million | $-79.74 Million | $22.34 Million | ▼ -23.6% |
| 2022 | -2.87x | $-72.68 Million | $-74.11 Million | $25.29 Million | ▼ -96.5% |
| 2021 | -1.46x | $-58.49 Million | $-60.25 Million | $40.00 Million | ▼ -963.1% |
| 2020 | -0.14x | $-37.06 Million | $-37.83 Million | $269.45 Million | ▼ -142.0% |
| 2019 | 0.33x | $48.24 Million | $47.93 Million | $147.44 Million | ▲ +292.6% |
| 2018 | -0.17x | $-11.30 Million | $-11.61 Million | $66.52 Million | — |